Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph S. Zakrzewski currently holds 64,503 shares of Cyteir Therapeutics, Inc. (CYT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph S. Zakrzewski has been a net seller of CYT stock. They have purchased $777.5K and sold $52.7M worth of shares.
Joseph S. Zakrzewski's most recent insider trade was on Aug 14, 2026, when they sold 405,880 shares at $0.00 per share.
Joseph S. Zakrzewski serves as Executive at Cyteir Therapeutics, Inc. (CYT). They have executed 133 insider transactions totaling $53.5M over their tenure at the company.
Joseph S. Zakrzewski holds the position of Executive at Cyteir Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Joseph S. Zakrzewski has shown a selling trading pattern, with $777.5K in total purchases and $52.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joseph S. Zakrzewski was on Jan 3, 2020, when they sold $6.3M worth of AMRN shares. This transaction involved 300,000 shares at $20.94 per share.
Joseph S. Zakrzewski currently owns 64,503 shares of Cyteir Therapeutics, Inc. (CYT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph S. Zakrzewski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph S. Zakrzewski has 133 Form 4 filings on record as an insider at Cyteir Therapeutics, Inc..
Set alerts for Joseph S. Zakrzewski and 40,000+ other insiders.